Chien Yung-Ching, Masica David L, Gray Jeffrey J, Nguyen Sarah, Vali Hojatollah, McKee Marc D
Faculty of Dentistry, McGill University, Montreal, Quebec H3A 2B2, Canada.
J Biol Chem. 2009 Aug 28;284(35):23491-501. doi: 10.1074/jbc.M109.021899. Epub 2009 Jul 6.
Calcium oxalate dihydrate (COD) mineral and the urinary protein osteopontin/uropontin (OPN) are commonly found in kidney stones. To investigate the effects of OPN on COD growth, COD crystals were grown with phosphorylated OPN or a polyaspartic acid-rich peptide of OPN (DDLDDDDD, poly-Asp(86-93)). Crystals grown with OPN showed increased dimensions of the {110} prismatic faces attributable to selective inhibition at this crystallographic face. At high concentrations of OPN, elongated crystals with dominant {110} faces were produced, often with intergrown, interpenetrating twin crystals. Poly-Asp(86-93) dose-dependently elongated crystal morphology along the {110} faces in a manner similar to OPN. In crystal growth studies using fluorescently tagged poly-Asp(86-93) followed by imaging of crystal interiors using confocal microscopy, sectoral (compositional) zoning in COD was observed resulting from selective binding and incorporation (occlusion) of peptide exclusively into {110} crystal sectors. Computational modeling of poly-Asp(86-93) adsorption to COD {110} and {101} surfaces also suggests increased stabilization of the COD {110} surface and negligible change to the natively stable {101} surface. Ultrastructural, colloidal-gold immunolocalization of OPN by transmission electron microscopy in human stones confirmed an intracrystalline distribution of OPN. In summary, OPN and its poly-Asp(86-93) sequence similarly affect COD mineral growth; the {110} crystallographic faces become enhanced and dominant attributable to {110} face inhibition by the protein/peptide, and peptides can incorporate into the mineral phase. We, thus, conclude that the poly-Asp(86-93) domain is central to the OPN ability to interact with the {110} faces of COD, where it binds to inhibit crystal growth with subsequent intracrystalline incorporation (occlusion).
二水合草酸钙(COD)矿物质和尿蛋白骨桥蛋白/尿桥蛋白(OPN)在肾结石中普遍存在。为了研究OPN对COD生长的影响,用磷酸化OPN或富含聚天冬氨酸的OPN肽(DDLDDDDD,聚天冬氨酸(86 - 93))培养COD晶体。用OPN培养的晶体显示{110}棱柱面尺寸增加,这归因于该晶面的选择性抑制。在高浓度OPN下,会产生具有主导{110}面的细长晶体,通常伴有共生、相互贯穿的孪晶。聚天冬氨酸(86 - 93)以类似于OPN的方式沿{110}面剂量依赖性地拉长晶体形态。在使用荧光标记的聚天冬氨酸(86 - 93)进行晶体生长研究,随后用共聚焦显微镜对晶体内部进行成像时,观察到COD中存在扇形(成分)分区,这是由于肽仅选择性地结合并掺入(封闭)到{110}晶体扇区中所致。聚天冬氨酸(86 - 93)吸附到COD {110}和{101}表面的计算模型也表明,COD {110}表面的稳定性增加,而对天然稳定的{101}表面的变化可忽略不计。通过透射电子显微镜对人结石中的OPN进行超微结构、胶体金免疫定位,证实了OPN在晶体内的分布。总之,OPN及其聚天冬氨酸(86 - 93)序列对COD矿物质生长的影响相似;由于蛋白质/肽对{110}面的抑制作用,{110}晶面增强并占主导地位,并且肽可以掺入矿物相中。因此,我们得出结论,聚天冬氨酸(86 - 93)结构域是OPN与COD的{110}面相互作用能力的核心,它在该晶面结合以抑制晶体生长,随后在晶体内掺入(封闭)。